The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: a placebo-controlled, double-blind …
Amir Englund, Zerrin Atakan, Aleksandra Kralj, Nigel Tunstall, Robin Murray, Paul Morrison
Journal of psychopharmacology 30 (2), 140-151, 2016
—-
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
RG Pertwee
British journal of pharmacology 153 (2), 199-215, 2008
“Δ9‐THCV behaves as a potent CB2 receptor partial agonist in vitro . In contrast, it antagonizes cannabinoid receptor agonists in CB1‐expressing tissues. This it does with relatively high potency and in a manner that is both tissue and ligand dependent. Δ9‐THCV also interacts with CB1 receptors when administered in vivo , behaving either as a CB1 antagonist or, at higher doses, as a CB1 receptor agonist.”
—
Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers
Luke Tudge, Clare Williams, Philip J Cowen, Ciara McCabe
International Journal of Neuropsychopharmacology 18 (6), 2015
“Our findings are the first to show that treatment with the CB1 neutral antagonist tetrahydrocannabivarin increases neural responding to rewarding and aversive stimuli. This effect profile suggests therapeutic activity in obesity, perhaps with a lowered risk of depressive side effects.”
Mention in this paper is a previously approved in Europe CB1 antagonist Rimonabant. It had issues with mood alteration and depressive thoughts. Cannabinoid receptors are very important to our mental state as well as things like appetite, pain regulation, and temperature regulation. These are great targets for medicinal benefits but we need to be careful with testing isolated minor cannabinoids in humans. Most are probably safe but with the rise of semi-synthetics and the known issues with full agonistic and antagonistic analogues, we need to be careful and test these substances in humans safely and ethically.
All papers I source from google scholar, any paywalled papers are accessed with sci-hub